DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Cellectis Q4 EPS $(0.73), Inline, Sales $6M Beat $4.95M Estimate

Cellectis (NASDAQ:CLLS) reported quarterly losses of $(0.73) per share which met the analyst consensus estimate. This is a 97.3 percent decrease over losses of $(0.37) per share from the same period last year. The

Benzinga · 03/04/2020 21:31

Cellectis (NASDAQ:CLLS) reported quarterly losses of $(0.73) per share which met the analyst consensus estimate. This is a 97.3 percent decrease over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $6 million which beat the analyst consensus estimate of $4.95 million by 21.21 percent. This is a 95.00 percent increase over sales of $3.077 million the same period last year.